Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$232.65 - $254.58 $256,147 - $280,292
-1,101 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $11,096 - $12,297
-50 Reduced 4.34%
1,101 $275,000
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $994,699 - $1.28 Million
-4,610 Reduced 80.02%
1,151 $268,000
Q2 2020

Aug 12, 2020

SELL
$219.9 - $263.41 $66,849 - $80,076
-304 Reduced 5.01%
5,761 $1.38 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $17,612 - $25,110
-90 Reduced 1.46%
6,065 $1.39 Million
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $27,428 - $30,951
-116 Reduced 1.85%
6,155 $1.67 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $11,529 - $12,804
-50 Reduced 0.79%
6,271 $1.59 Million
Q2 2019

Aug 13, 2019

SELL
$217.4 - $246.08 $60,654 - $68,656
-279 Reduced 4.23%
6,321 $1.59 Million
Q1 2019

May 13, 2019

SELL
$206.05 - $248.17 $19,574 - $23,576
-95 Reduced 1.42%
6,600 $1.65 Million
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $2,047 - $2,579
10 Added 0.15%
6,695 $1.51 Million
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $25,637 - $28,160
-110 Reduced 1.62%
6,685 $1.75 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $90,731 - $101,958
-436 Reduced 6.03%
6,795 $1.63 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $30,202 - $35,319
147 Added 2.08%
7,231 $1.57 Million
Q4 2017

Feb 14, 2018

SELL
$189.0 - $222.64 $10,395 - $12,245
-55 Reduced 0.77%
7,084 $1.52 Million
Q3 2017

Nov 09, 2017

BUY
$186.89 - $198.9 $1.33 Million - $1.42 Million
7,139
7,139 $1.4 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Trustmark National Bank Trust Department Portfolio

Follow Trustmark National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Trustmark National Bank Trust Department with notifications on news.